What is compounded semaglutide
left alone, it can progress to MASH, fibrosis, and cirrhosis. Tirzepatide trials in MASLD/MASH show meaningful drops in liver fat, liver enzymes, and inflammatory changes on biopsy, with higher rates of NASH/MASH resolution and fibrosis improvement compared with placebo. Semaglutide also improves MASLD and MASH: phase 2 and phase 3 work, plus large realworld cohorts, link it to better liver histology, less fibrosis progression, and improved survival in MASLD patients versus controls. Both drugs are legitimate liverprotection tools in metabolic disease
Convenience: Administered via a once-weekly injection, Tirzepatide offers a convenient and manageable treatment option for patients
Stomach acid, along with bile, plays a protective role in this process
The presence of parakeratosis, spongiosis, extravasated red blood cells, dyskeratotic keratinocytes, and the melanin pigment above the suprabasal layer is a hint that a lesion has been traumatized
They help regulate blood sugar